NBIX
Neurocrine Biosciences Inc.Stock · Health Care$150.80−$5.69 (-3.64%)as of market close, Aug 13, 2026
☾ After hours:$150.82+0.00%3:59 PM ET
NBIX — Neurocrine Biosciences Inc. stock price, chart and key statistics
Key stats#
Price data
- Price
- $150.80
- Change YTD
- +6.32%
- Market cap
- 15.3B
- Enterprise value
- 15.5B
- Shares outstanding
- 101.6M
- 52W low
- $122.14
- 52W high
- $186.12
- From 52W high
- -18.98%
- From 52W low
- +23.46%
- 52W range
- 45%
- Beta
- 0.39
Volume
- Rel volume
- 1.40×
- 30D volume
- 1.3M
- 30D $ vol
- 226.8M
Fundamentals
- Sales (ttm)
- 3.4B
- Sales/share
- $33.19
- EPS (ttm)
- $6.81
- FCF (ttm)
- 870.4M
- FCF/share
- $8.56
- Book value/share
- $36.34
- Net margin
- 20.91%
- ROE
- 19.10%
- ROA
- 13.16%
- Current ratio
- 1.87
Growth (CAGR, ttm) · 10Y
- Sales
- +71.88%
- Net income
- n/a
- FCF
- n/a
- Shares
- +1.60%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- +69.18%
- FCF/share
- n/a
- Book value/share
- +23.53%
- Price
- +12.04%
- Total return
- +12.04%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- 22.1×
- 19.3×
- Fwd P/E
- 13.3×
- 4.5×
- 4.2×
- 17.6×
- EV/EBITDA (fy)
- 18.4×
- EV/Sales (ttm)
- 4.6×
- 5.68%
- -2.49%
- -2.49%
- -0.82%
- -0.82%
Vs own 10Y history
- P/E
- 5th
- P/OI
- 2nd
- P/S
- 3rd
- P/B
- 3rd
- P/FCF
- 3rd
Bar = where today's multiple sits in NBIX's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return#
1D
-3.64%
1W
-5.64%
1M
-12.35%
3M
-6.52%
YTD
+6.32%
1Y
+17.00%
5Y
+62.69%
Financial statements
Open full NBIX financials →Related Health Care#
1MNeurocrine Biosciences Inc. (NBIX) trades at $150.80 with a live price and an interactive chart covering 30+ years of daily price history, plus key valuation metrics. ChartRow also publishes NBIX's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full NBIX financial statements →
